Unknown

Dataset Information

0

Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.


ABSTRACT: BACKGROUND/AIMS:Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in hospitals, and has recently emerged in the community. The impact of methicillin-resistance on mortality and medical costs for patients with S. aureus bacteremia (SAB) requires reevaluation. METHODS:We searched studies with SAB or endocarditis using electronic databases including Ovid-Medline, Embase-Medline, and Cochrane Library, as well as five local databases for published studies during the period January 2000 to September 2011. RESULTS:A total of 2,841 studies were identified, 62 of which involved 17,563 adult subjects and were selected as eligible. A significant increase in overall mortality associated with MRSA, compared to that with methicillin-susceptible S. aureus (MSSA), was evidenced by an odds ratio (OR) of 1.95 (95% confidence interval [CI], 1.73 to 2.21; p < 0.01). In 13 endocarditis studies, MRSA increased the risk of mortality, with an OR of 2.65 (95% CI, 1.46 to 4.80). When three studies, which compared mortality rates between CA-MRSA and CA-MSSA, were combined, the risk of methicillin-resistance increased 3.23-fold compared to MSSA (95% CI, 1.25 to 8.34). The length of hospital stay in the MRSA group was 10 days longer than that in the MSSA group (95% CI, 3.36 to 16.70). Of six studies that reported medical costs, two were included in the analysis, which estimated medical costs to be $9,954.58 (95% CI, 8,951.99 to 10,957.17). CONCLUSION:MRSA is still associated with increased mortality, longer hospital stays and medical costs, compared with MSSA in SAB in studies published since the year 2000.

SUBMITTER: Joo EJ 

PROVIDER: S-EPMC6823568 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.

Joo Eun-Jeong EJ   Park Dong Ah DA   Kang Cheol-In CI   Chung Doo Ryeon DR   Song Jae-Hoon JH   Lee Sang Moo SM   Peck Kyong Ran KR  

The Korean journal of internal medicine 20180120 6


<h4>Background/aims</h4>Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in hospitals, and has recently emerged in the community. The impact of methicillin-resistance on mortality and medical costs for patients with S. aureus bacteremia (SAB) requires reevaluation.<h4>Methods</h4>We searched studies with SAB or endocarditis using electronic databases including Ovid-Medline, Embase-Medline, and Cochrane Library, as well as five local databases for published studies during th  ...[more]

Similar Datasets

| S-EPMC5204005 | biostudies-other
| S-EPMC6085790 | biostudies-other
| S-EPMC4760414 | biostudies-literature
| S-EPMC4542891 | biostudies-literature
| S-EPMC5119028 | biostudies-literature
| S-EPMC4281789 | biostudies-literature
| S-EPMC4546585 | biostudies-literature
| S-EPMC8117599 | biostudies-literature
| S-EPMC4686456 | biostudies-other
| S-EPMC8096235 | biostudies-literature